Supplemental Financial Information (Tables)

3 Months Ended

Mar. 31, 2025

Supplemental Financial Statement Information [Abstract]

Schedule of Cash, Cash Equivalents and Restricted Cash

The reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet to the totals shown within the condensed consolidated statements of cash flows is as follows (in thousands):

	As of March 31,
	2025		2024
Cash and cash equivalents	$	312,420	$	840,440
Restricted cash included in prepaid expenses and other current assets (1)	7,943		3,328
Restricted cash included in other non-current assets (1)	35,042		43,445
Total cash, cash equivalents and restricted cash	$	355,405	$	887,213

(1)Includes cash balances collateralizing letters of credit associated with the Company’s facility leases and customer prepayments requiring segregation and restrictions in its use in accordance with the customer agreement.

Schedule of Cash and Cash Equivalents

The reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet to the totals shown within the condensed consolidated statements of cash flows is as follows (in thousands):

	As of March 31,
	2025		2024
Cash and cash equivalents	$	312,420	$	840,440
Restricted cash included in prepaid expenses and other current assets (1)	7,943		3,328
Restricted cash included in other non-current assets (1)	35,042		43,445
Total cash, cash equivalents and restricted cash	$	355,405	$	887,213

(1)Includes cash balances collateralizing letters of credit associated with the Company’s facility leases and customer prepayments requiring segregation and restrictions in its use in accordance with the customer agreement.

Schedule of Supplemental Cash Flow Information

The following table presents non-cash investing and financing activities (in thousands):

	Three Months Ended March 31,
	2025		2024
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses	$	96	$	7,886
Common stock issued as settlement of contingent consideration liability	—		1,877

Summary of Property and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):

	As of March 31,		As of December 31,
	2025		2024
Lab equipment	$	148,815	$	150,887
Leasehold improvements	140,407		135,964
Buildings and facilities	48,294		48,255
Construction in progress	1,453		1,984
Computer equipment and software	9,674		14,897
Furniture and fixtures	6,546		6,545
Land	6,060		6,060
Total property, plant and equipment	361,249		364,592
Less: Accumulated depreciation	(163,421)		(160,872)
Property, plant and equipment, net	$	197,828	$	203,720

Schedule of Capitalization

The following table presents the Company’s authorized, issued, and outstanding common stock as of the dates indicated:

	Authorized	Issued	Outstanding
Common stock as of March 31, 2025:
Class A	10,500,000,000	45,955,211	43,075,350
Class B	4,500,000,000	9,193,344	8,622,896
Class C	800,000,000	3,000,000	3,000,000
	15,800,000,000	58,148,555	54,698,246
Common stock as of December 31, 2024:
Class A	10,500,000,000	45,575,423	42,696,585
Class B	4,500,000,000	9,239,682	8,669,200
Class C	800,000,000	3,000,000	3,000,000
	15,800,000,000	57,815,105	54,365,785